The largest of these by Choi et al used DNA sequencing and identified RB1 mutant status to be associated with shorter disease‐free survival only in early stage adenocarcinoma.21 The incidence of RB1 mutation of 5.9% in their cohort is comparable to ours. The gene discussed is RB1; the disease is adenocarcinoma.